Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Identify which cards provide flexible rewards without any fees. Compare your options for optimal rewards.
26,016 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
California Gov. Gavin Newsom warned 15 cities and counties they have 30 days to align their zoning with SB 79 or face...
Microsoft leans on three strategic ties—OpenAI, hardware collaboration with AMD, and Copilot enterprise adoption—to s...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
As AI demand accelerates, one company stands out for investors: TSMC. This article explains why the so-called tsmc mo...
A broad rally in nuclear stocks helped Constellation Energy ride the wave. This piece breaks down the catalysts, what...
Pipe Network unveils SolanaCDN, a free, open-source validator client with an integrated CDN layer designed to speed u...
As Reynolds prepares to report its 2026 earnings, investors are weighing growth catalysts, margin resilience, and pot...
D-Wave QBTS delivered a notable Q4 2025 run, with rising revenue and expanding services. This story breaks down what ...
A JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
MortgageOne TPO announces an ARIVE integration alongside the Pathway CDFI loan program, aiming to broaden homeownersh...